EmilyDanaBetheaMD

PubMed

• Financial burden following adult liver transplantation is common and associated with adverse recipient outcomes.
  Nneka N Ufere, Marina Serper, Alyson Kaplan, Nora Horick, Teresa Indriolo, Lucinda Li, Nishant Satapathy, John Donlan, Janeth C Castano Jimenez, Carlos Lago-Hernandez,...> ;Liver Transplantation. 2024 Feb 15
• Health care-related transportation insecurity is associated with adverse health outcomes among adults with chronic liver disease.
  Alejandro-Soto, A., Walker, T., Li, L., Schoener, K., Keegan, E., Gonzalez, C., Jones, P., Ufere, N., Lago-Hernandez, C., Bethea, E., Singh, S., El-Jawahri, A., Nephew...> ;Hepatology Communications. 2024 Jan 1
• Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response.
  Mauricio A Villavicencio, Selena S Li, Ann Marie Leifer, Jenna L Gustafson, Asishana Osho, Stanley Wolfe, Yuval Raz, Jason Griffith, Isabel Neuringer, Emily Bethea, Th...> ;JTCVS Open. 2023 Jun 1
• The incidence and natural history of ascites after liver transplantation.
  Patricia P Bloom, Timothy Gilbert, Keli Santos-Parker, Zoe Memel, Eric Przybyszewski, Emily Bethea, Christopher J Sonnenday, Elliot B Tapper, Seth Waits> ;Hepatology Communications. 2023 Jun 1
• 5 citations
  Resection of NAFLD/NASH-related Hepatocellular Carcinoma (HCC): Clinical Features and Outcomes Compared with HCC Due to Other Etiologies.
  Surendra Pal Chaudhary, Stephanie Reyes, Matthew L Chase, Aparna Govindan, Lei Zhao, Jay Luther, Irun Bhan, Emily Bethea, Joseph W Franses, Elizabeth Paige Walsh, Leig...> ;The Oncologist. 2023 Apr 6
• 15 citations
  Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication.
  Peter P Mueller, Qiushi Chen, Turgay Ayer, Gizem S Nemutlu, Ali Hajjar, Emily D Bethea, Mary Linton B Peters, Brian P Lee, Naveed Z Janjua, Fasiha Kanwal, Jagpreet Chh...> ;Journal of Hepatology. 2022 Jul 1
• 5 citations
  Temporal Trends and Impact of Willingness to Accept Organs from Donors with Hepatitis C Virus
  Qing Yuan, Hanwen Cui, Greg A. Leya, Shanjuan Hong, Eve M. Roth, Meghan E. Sise, Emily D. Bethea, Heidi Yeh, Winfred W. Williams, Nahel Elias> ;Transplant International. 2021 Nov 2
• Influence of donor and recipient hepatitis B virus infection on long-term outcomes after kidney transplantation.
  Qing Yuan, Omar Sultan Haque, Shanjuan Hong, Andric Ortiz, Emily D. Bethea, Meghan E. Sise, James F. Markmann, Nahel Elias> ;Clinical Transplantation. 2021 Oct 21
• 10 citations
  Transjugular Intrahepatic Portosystemic Shunt Placement for Portal Hypertension: Meta-Analysis of Safety and Efficacy of 8 mm vs. 10 mm Stents.
  Jiangtao Liu, Eric Wehrenberg-Klee, Emily D. Bethea, Raul N. Uppot, Kei Yamada, Suvranu Ganguli> ;Gastroenterology Research and Practice. 2020 Oct 17
• Liver transplantation with suprahepatic caval anastomosis including inferior vena cava stent.
  Taylor M. Coe, Mari Tanaka, Emily D. Bethea, David A. D'Alessandro, Shoko Kimura, Heidi Yeh, James F. Markmann> ;Transplantation Reports. 2020 Aug 11
• 73 citations
  Projected prevalence and mortality associated with alcohol-related liver disease in the USA, 2019-40: a modelling study.
  Jovan Julien, Turgay Ayer, Emily D. Bethea, Elliot B. Tapper, Jagpreet Chhatwal> ;The Lancet. Public Health. 2020 Jun 1
• 24 citations
  Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.
  Emily D. Bethea, Ashwini Arvind, Jenna L. Gustafson, Karin L. Andersson, Daniel Pratt, Irun Bhan, Michael Thiim, Kathleen E. Corey, Patricia P. Bloom, J. Markmann, Hei...> ;American Journal of Transplantation. 2020 Feb 3
• Residents Take the Lead: A Modern Collaborative Approach to Research During Residency
  Alev J. Atalay, Kevin L. Ard, Emily D. Bethea, Kenneth B. Christopher, Maria A Yialamas> ;Advances in Medical Education and Practice. 2020 Feb 18
• 8 citations
  Do Social Determinants Define "Too Sick" to Transplant in Patients With End-stage Liver Disease?
  Yanik J. Bababekov, Ya-Ching Hung, David C. Chang, Charles G. Rickert, Joel T. Adler, Emily D. Bethea, Elizabeth A. Pomfret, James J. Pomposelli, Heidi Yeh> ;Transplantation. 2020 Feb 1
• 1 citations
  Computed Tomography Findings as a Novel Predictor of Alcohol-Associated Hepatitis Outcomes
  Patricia P. Bloom, Amirkasra Mojtahed, Emily D. Bethea, Sally A.I. Knooihuizen, Jin G. Choi, Jules L. Dienstag, Raymond T. Chung, Chin Hur> ;Digestive Diseases and Sciences. 2020 Jan 1
• 55 citations
  Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study
  Emily D. Bethea, Kerry Gaj, Jenna L. Gustafson, Andrea L. Axtell, T Lebeis, Mark W. Schoenike, Karen Turvey, Erin Coglianese, Sunu S. Thomas, Christopher Newton-Cheh, ...> ;The Lancet. Gastroenterology & Hepatology. 2019 Jul 26
• 32 citations
  Model to Calculate Harms and Benefits of Early vs Delayed Liver Transplantation for Patients With Alcohol-Associated Hepatitis
  Brian Lee, Sumeyye Samur, Ozden O. Dalgic, Emily D. Bethea, Michael R. Lucey, Ethan M. Weinberg, Christine Hsu, Mary E. Rinella, Gene Y. Im, Oren K. Fix, George Therap...> ;Gastroenterology. 2019 Aug 1
• 36 citations
  The impact of direct‐acting anti‐virals on the hepatitis C care cascade: identifying progress and gaps towards hepatitis C elimination in the United States
  Jagpreet Chhatwal, Qiushi Chen, Emily D. Bethea, Chin Hur, Anne C. Spaulding, Fasiha Kanwal> ;Alimentary Pharmacology & Therapeutics. 2019 Jul 1
• 32 citations
  Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study.
  Qiushi Chen, Turgay Ayer, Emily D. Bethea, Fasiha Kanwal, Xiaojie Wang, Mark S. Roberts, Yueran Zhuo, Stefano Fagiuoli, Jorg Petersen, Jagpreet Chhatwal> ;BMJ Open. 2019 Jun 1
• 1 citations
  Balancing the risk and rewards of utilizing organs from hepatitis C viremic donors.
  Meghan E Sise, Ian A Strohbehn, Emily Bethea, Jenna L Gustafson, Raymond T Chung> ;Current Opinion in Organ Transplantation. 2019 Jun 1
• Balancing the risk and rewards of utilizing organs from hepatitis C viremic donors.
  Sise, M. E.,Strohbehn, I. A.,Bethea, E.,Gustafson, J. L.,Chung, R. T.> ;Curr Opin Organ Transplant. 2019 Apr 23
• 21 citations
  Hep C Calculator: an online tool for cost-effectiveness analysis of DAAs
  Jagpreet Chhatwal, Qiushi Chen, Emily D. Bethea, Mary Ann Ladd, Peter P. Mueller, Yvan Hutin, Rakesh Aggarwal> ;The Lancet. Gastroenterology & Hepatology. 2018 Dec 1
• 20 citations
  Cost Effectiveness of Transplanting HCV-Infected Livers Into Uninfected Recipients With Preemptive Antiviral Therapy
  Emily D. Bethea, Sumeyye Samur, Fasiha Kanwal, Turgay Ayer, Chin Hur, Mark S. Roberts, Norah A. Terrault, Raymond T. Chung, Jagpreet Chhatwal> ;Clinical Gastroenterology and Hepatology. 2019 Mar 1
• 38 citations
  Transplanting hepatitis C virus-positive livers into hepatitis C virus-negative patients with preemptive antiviral treatment: A modeling study.
  Jagpreet Chhatwal, Sumeyye Samur, Emily D. Bethea, Turgay Ayer, Fasiha Kanwal, Chin Hur, Mark S. Roberts, Norah A. Terrault, Raymond T. Chung> ;Hepatology. 2018 Jun 1
• 21 citations
  Hepatitis C virus re-treatment in the era of direct-acting antivirals: projections in the USA.
  Jagpreet Chhatwal, Qiushi Chen, Turgay Ayer, Emily D. Bethea, Fasiha Kanwal, Kris V. Kowdley, Xiaojie Wang, Mark S. Roberts, Stuart C Gordon> ;Alimentary Pharmacology & Therapeutics. 2018 Apr 1
• Join now to see all